LabCorp Extends Tender Offer for Orchid Cellmark as FTC Requests More Information

As of May 17, Orchid shareholders had tendered and not withdrawn about 85 percent of the company's outstanding shares.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories